A systematic review of commencing full-dose antihypertensives in newly diagnosed hypertension
Article 2025 en
Authors
BK
Babu Karavadra
AD
Alessandro D’Elia
AS
Alena Shantsila
Abstract
1 min read
This review indicates that initiating full-dose antihypertensives for essential hypertension may be beneficial and safe. The available data are limited, and further RCTs are required to assess this in specific patient groups to assess safety and efficac.
Peta Edler, Megha Rajasekhar, David J. Price, Ishag Adam, Ghulam Rahim Awab, Bridget E. Barber, Larissa W. Brasil, Nathália N. Chamma-Siqueira, Cindy S. Chu, Liwang Cui, André Daher, Lilia González-Cerón, Matthew J. Grigg, Harin Karunajeewa, Marcus V. G. Lacerda, Simone Ladeia-Andrade, Toby Leslie, Benedikt Ley, Kartini Lidia, Alejandro Llanos‐Cuentas, Rhea J. Longley, Laurens Manning, Daniel Abebe Mekonnen, Wuelton Marcelo Monteiro, Brioni R. Moore, François Nosten, Ayodhia Pitaloka Pasaribu, Dhélio B. Pereira, Jeanne Rini Poespoprodjo, Sasithon Pukrittayakamee, Komal Raj Rijal, Kavitha Saravu, André M. Siqueira, Inge Sutanto, Walter R J Taylor, Pham Vinh Thanh, Kamala Thriemer, Sir Nicholas White, Asnakew K. Yeshiwondim, Lina M. Zuluaga-Idarraga, Philippe J. Guérin, Julie A. Simpson, Ric N. Price, Robert J. Commons
Nicola Veronese, Jacopo Demurtas, Trevor Thompson, Marco Solmi, Gabriella Pesolillo, Stefano Celotto, Tommaso Barnini, Brendon Stubbs, Stefania Maggi, Alberto Pilotto, Graziano Onder, Evropi Τheodoratou, Alberto Vaona, Joseph Firth, Lee Smith, Ai Koyanagi, John P A Ioannidis, Ioanna Tzoulaki
María Reinares, Adriane Ribeiro Rosa, Carolina Franco, José Manuel Goikolea, Konstantinos Ν. Fountoulakis, Melina Siamouli, Xénia Gonda, Sophia Frangou, Eduard Vieta
Discussion(0)
No comments yet. Be the first to comment.